DEFR14A: IFF Seeks Shareholder Approval for Amended Equity Incentive Plan, Details Executive Compensation and Governance

International Flavors & Fragrances Inc. is asking shareholders to approve an amended equity incentive plan and provides detailed information on executive compensation, corporate governance, and upcoming annual meeting proposals.

Summary

• International Flavors & Fragrances Inc. (IFF) has filed an amendment to its proxy statement to include inline XBRL data tagging for pay versus performance disclosures and additional information regarding its clawback policy.
• The company's 2024 Annual Meeting of Shareholders will be held on May 1, 2024, and will include proposals for the election of directors, ratification of the independent accounting firm, approval of executive compensation, approval of the amended 2021 Stock Award and Incentive Plan, and a shareholder proposal regarding freedom of association and collective bargaining rights.
• IFF's Board recommends voting for the election of all director nominees, ratification of PricewaterhouseCoopers LLP, and approval of executive compensation and the amended stock award plan, but recommends voting against the shareholder proposal.
• The company highlights its corporate governance policies, including director independence, pay-for-performance practices, board diversity, and executive clawback policies.
• IFF's executive compensation program is designed to align with the achievement of financial and operational metrics and to tie compensation to Total Shareholder Return (TSR).
• The company's Human Capital & Compensation Committee made changes to the executive compensation program for the 2023 fiscal year, including replacing the Equity Choice Program with awards comprised 100% of RSUs and switching from 3-year cliff vesting to 3-year ratable vesting on RSUs.
• The company's Human Capital & Compensation Committee also approved changes to the AIP design that simplify the design and enhance emphasis on profitable growth for 2024.
• The company is seeking shareholder approval for an additional 6,900,000 shares to be reserved for grant under the Amended and Restated 2021 Stock Award and Incentive Plan.
• The company's clawback policy allows for the recovery of erroneously awarded compensation from current and former executive officers in the event of an accounting restatement.
• The company's Board is actively involved in the oversight of risks that could affect the company and is responsible for overseeing and reviewing with management the company's enterprise-wide risks and the policies and practices established to manage such risks.

Sentiment

Score: 6

Explanation: The document presents a mixed sentiment. While it highlights positive aspects like corporate governance and ESG efforts, it also acknowledges financial challenges and the need for improvement. The overall tone is cautiously optimistic, but the presence of negative financial results and risks tempers the positive aspects.

Positives

• The company has a strong commitment to corporate governance, including director independence, pay-for-performance practices, and board diversity.
• The executive compensation program is designed to align with financial and operational metrics and Total Shareholder Return (TSR).
• The company has a robust executive clawback policy, which goes beyond the minimum requirements of the NYSE listing standards.
• The company is committed to environmental, social, and governance (ESG) initiatives and has received recognition from reputable third-party organizations.
• The company regularly engages with its shareholders to better understand their perspectives on the company's strategies, performance, and governance.
• The company has a strong succession planning process in place to ensure excellence and continuity in senior leadership.

Negatives

• The company reported an operating loss of $(2.1) billion and a diluted EPS of $(10.05) for 2023.
• The company's end markets in Scent and Health and Biosciences remained resilient, reflected by their strong sales and EBITDA performance, but lower volumes and inventory challenges in Functional Ingredients led to reduced sales and EBITDA year on year in the Nourish division.
• The company's 2021-2023 LTIP cycle resulted in NEOs forfeiting the 2023 segment of the 2021-2023 LTIP cycle.
• The company's 2021-2023 LTIP cycle resulted in NEOs earning only 11.7% of the target awards for 2021 2023 LTIP cycle based on 2021 Net Debt Ratio results.

Risks

• The company acknowledges the uncertain global economic landscape and the need to remain focused on execution.
• The company's forward-looking statements are qualified by cautionary statements and risk factor disclosures contained in the company's SEC filings.
• The company's business is subject to various risks, including operational risk, financial risk, regulatory risk, litigation risk, cybersecurity and information security risk, tax risk, credit risk, liquidity risk, and compliance risk.
• The company's business is subject to risks related to shareholder activism, cybersecurity breaches, raw material sourcing and availability, facilities and production quality, technology and innovation, geopolitical risk, sustainability, and integration/divestiture of business segments.

Future Outlook

While the global economic landscape is uncertain, IFF will remain focused on execution and is well-positioned to build on its strong progress in 2023 and create enduring value for all stakeholders in 2024 and beyond.

Management Comments

• IFFers demonstrated remarkable creativity and resilience, finding new ways to innovate for our global customers and deliver exceptional experiences for end consumers.
• Our performance reflects the execution of our strategic priorities, including our renewed focus on commercial success and operating efficiency.
• IFF took decisive action to ensure our portfolio best positions the company for long-term growth, improves our capital structure and allows for greater investment in high-return businesses.
• IFF is an iconic business built upon a legacy of incredible innovation and backed by world-class teams across the globe.
• IFF continues to advance our vision for people and the planet.
• This unifying commitment to apply science and creativity for a better world will continue to guide IFF through our next chapter.

Industry Context

The announcement reflects IFF's efforts to optimize its portfolio, strengthen corporate governance, and advance ESG initiatives, aligning with broader industry trends towards sustainability and responsible business practices. The company's focus on innovation and customer-centricity is also consistent with the competitive landscape in the flavors and fragrances industry.

Comparison to Industry Standards

• IFF's compensation practices, including the use of peer groups for benchmarking and the emphasis on performance-based pay, are consistent with industry standards.
• The company's clawback policy is more robust than the minimum requirements of the NYSE listing standards, demonstrating a commitment to accountability.
• IFF's ESG efforts, including its inclusion in the Dow Jones Sustainability Indices and recognition by CDP, position it as a leader in sustainability performance within its industry.
• The company's share usage and overhang are within reasonable ranges compared to its industry peers.
• IFF's corporate governance practices, such as the separation of the Chair and CEO roles and the use of independent directors, align with best practices in corporate governance.

Management Changes

Corporate Governance

Legal Proceedings

• The union has alleged that IFF committed unfair labor practices by refusing to bargain in good faith, but IFF has denied these charges, and the unfair labor practice charges were pending before the National Labor Relations Board as of November 2023 when this shareholder proposal was submitted.

Related Party Transactions

• In 2023, there were no transactions and there are no currently proposed transactions in excess of $120,000 in which the Company was or will be a participant and in which any director or executive officer of the Company, any known 5% or greater shareholder of the Company or any immediate family member of any of the foregoing persons, had or will have a direct or indirect material interest as defined in Item 404(a) of Regulation S-K.

Stakeholder Impact

• The company's performance and strategic decisions impact shareholders, employees, customers, suppliers, and communities.
• The company's ESG efforts aim to create a better world through science and creativity and drive long-term shareholder value.
• The company's human capital management programs support employees to best deliver the business strategy and ensure their development and engagement.

Next Steps

• Shareholders are encouraged to vote on the proposals outlined in the proxy statement.
• The Board and management will consider the outcome of the advisory vote on executive compensation in future compensation decisions.
• The company will continue to execute its strategic priorities and focus on long-term profitable growth.
• The company will continue to work diligently to execute other portfolio efforts during the remainder of 2024.

Key Dates

Keywords

executive compensation, corporate governance, shareholder meeting, equity incentive plan, clawback policy, director nominees, risk management, ESG, sustainability, IFF, proxy statement, directors, compensation, incentive, officers, board